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Abstract
Background: Diabetes is highly prevalent in the Caribbean, associated with a high morbidity and mortality and is a
recognised threat to economic and social development. Heads of Government in the Caribbean Community came
together in 2007 and declared their commitment to reducing the burden of non-communicable diseases (NCDs),
including diabetes, by calling for a multi-sectoral, systemic response. To facilitate the development of effective
policies, policymakers are being engaged in the development and use of a system dynamics (SD) model of
diabetes for Caribbean countries.
Methods: Previous work on a diabetes SD model from the United States of America (USA) is being adapted to a local
context for three countries in the region using input from stakeholders, a review of existing qualitative and quantitative
data, and collection of new qualitative data. Three country models will be developed using one-on-one stakeholder
engagement and iterative revision. An inter-country model will also be developed following a model-building
workshop. Models will be compared to each other and to the USA model. The inter-country model will be used to
simulate policies identified as priorities by stakeholders and to develop targets for prevention and control. The model
and model-building process will be evaluated by stakeholders and a manual developed for use in other high-burden
developing regions.
Discussion: SD has been applied with success for health policy development in high-income country settings. The
utility of SD in developing countries as an aid to policy decision-making related to NCDs has not been tested. This
study represents the first of its kind.
Keywords: System dynamics modelling, Health policy, Policy simulation, Non-communicable disease, Developing
countries, Diabetes
Background
Diabetes, the vast majority of which is type 2 diabetes, is
estimated to affect over 8% of the global adult population,
with 80% of all cases in low- and middle-income countries
(LMICs) [1]. Diabetes is associated with a marked in-
creased mortality, particularly in younger and middle-aged
adults [2], and with healthcare costs that are on average
two to three times higher than in age- and sex-matched
individuals without diabetes [3]. In common with many
other middle-income regions and countries, the Caribbean
has high diabetes prevalence, estimated to affect between
10% and 20% of most adult populations [1, 4]. Age-ad-
justed mortality from diabetes in the Caribbean is 35%
higher than in the neighbouring United States of America
(USA) [5] and complication rates, where they have been
studied, such as lower extremity amputation [6], are
among the highest recorded rates. The prevalence of dia-
betes continues to rise in the Caribbean, as it does in other
LMICs [1], associated with an increasing prevalence of the
major risk factors for type 2 diabetes, especially over-
weight and obesity, and physical inactivity [7, 8]. The
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prevention of type 2 diabetes, and the management of
people with diabetes, present major challenges to health
systems in LMICs.
The threat posed to the economic and social
development of the Caribbean by diabetes and related
non-communicable diseases (NCDs) was recognised by the
Heads of Government summit of the Caribbean Commu-
nity (CARICOM) in 2007, resulting in the Port of Spain
Summit Declaration on NCDs (POSD) [9]. This was a
world first for intergovernmental action on NCDs in a
middle-income region, and it strongly influenced the
initiation and content of the United Nations High Level
Meeting on NCDs in September 2011. Both the POSD and
United Nations meeting outputs (including the subsequent
WHO Global Action Plan [10]) strongly emphasise the im-
portance of policy measures for reducing NCD risk factors.
However, evidence on how to achieve a reduction in
overweight/obesity and physical inactivity at the population
level is scarce. Despite the fact that governments in
CARICOM are publically and officially committed to
addressing NCDs, progress on achieving the goals set forth
in the POSD has been varied [11].
It is increasingly acknowledged that the determinants of
obesity and physical inactivity are embedded in the organ-
isation of modern societies [12]. Systems science offers
advantages over other multilevel or ecological frameworks
in identifying the most effective points to intervene [13].
System dynamics modelling has established a methodology
for engaging with policymakers and other stakeholders to
facilitate broader thinking on the mechanisms and effects
of complex problems such as type 2 diabetes and other
NCDs. This includes the use of stakeholder in-depth
interviews and group model building workshops to build
and refine qualitative conceptual system models and quan-
titative models, and can use games or ‘flight simulators’ for
appraising the potential impact of different policy options
as an aid to policy decision-making [14].
System dynamics models in diabetes and NCDs
System dynamics models have been recognised for their
importance and potential in public health [15] and
successfully used in high-income settings, especially in
the USA, in guiding policy for the prevention and
control of NCDs. The Centers of Disease Control and
Prevention (CDC) sponsored the development of disease
models for diabetes [16] and obesity [17], as well as a
national chronic disease strategy [18] that enabled
simulation of the trajectories of NCDs and supported
appropriate public health planning in the country.
Another more locally-based model looked at health
planning and system structure for NCD management
and prevention [19] in Washington State. Beyond the
USA, New Zealand adapted the USA Cardiovascular
Disease Prevention model [20] to its context and used it
for health planning, while a team in Canada developed a
stratified model to look at the social determinants of
disease in Toronto and its effects on underserved popu-
lations [21]. While all of these models show promise in
using system dynamics methodologies for health policy
and planning, none have been extended to NCDs in
LMICs or engaged directly with policymakers.
The study described here is adapting and developing a
system dynamics model to guide policy on the prevention
and control of diabetes in a middle-income region, using a
process designed to fully engage with policymakers and
other multi-sectoral stakeholders, and evaluate the utility
of the process and resulting simulation model from their
perspective.
Study objectives
The overarching aim of the study is to use system
dynamics modelling to explain the rise in the diabetes
burden for middle-income countries in the Caribbean
and assist in policy decision-making through appraising
the potential impact of different strategies and policies
for prevention and control.
The main study phases will be to:
1. Undertake, with policymakers and other stakeholders,
in-depth interviews and a quantitative data evidence
review on the systems driving obesity, physical
inactivity and access to effective diabetes care
2. Accordingly develop a model for use in the
Caribbean, based on the conceptual models and
evidence reviews
3. Use, along with policymakers, the simulation model
to explore the potential impacts and interactions of
different policy options, including the feasibility of
achieving relevant targets from the WHO Global
Monitoring Framework [22]
4. Evaluate from the perspectives of the policymakers
and stakeholders the utility of both the qualitative
and quantitative aspects of the modelling process
Design
Setting and target populations: building on the POSD
evaluation study
A multi-country evaluation of the impact of the 2007
POSD is currently underway (POSD evaluation study:
http://www.onecaribbeanhealth.org/), led by the University
of the West Indies, to assess successes and gaps in the
development and implementation of policy on NCDs in the
Caribbean region. The POSD evaluation study has
developed a network of stakeholders and collected a range
of qualitative and quantitative data that can serve directly
as resources for the development of the model described
here. As part of this study, data are being collated on
mortality, morbidity and risk factor trends across the 20
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CARICOM member states. A core component of the
POSD evaluation study were case studies in seven
Caribbean countries of the policy responses to NCDs,
including qualitative in-depth interviews with stakeholders
from government and other sectors. In addition, govern-
ment and regional policy initiatives around the prevention
and control of NCDs since 2007 are being appraised. The
model development will build on findings and stakeholder
contacts from the POSD evaluation study (Fig. 1).
Middle-income countries were chosen to evaluate system
dynamics methodologies in health in resource-limited
settings. One country is Jamaica, as the largest English-
speaking middle-income country in the Caribbean. The
second is Belize, which is politically and culturally part of
the Caribbean, but has a unique environment being a
Central American mainland, English-speaking middle-
income country with access to data on diabetes prevalence,
risk factors and its effects from continuing monitoring in
the country. The third is St Vincent and the Grenadines, a
small, middle-income island nation.
Development of an initial conceptual model
Milstein et al. [23] developed a comprehensive diabetes
model for the CDC in the USA to reflect, as much as
possible, a generic model for diabetes. The core of this
model will be used as a basis in this project. The CDC
model will be adapted to a Caribbean context, which
differs from the USA in demographics, ethnic admixture,
health system structure, food policy, built environment
and resources. Furthermore, policymakers participating
in the POSD evaluation study have expressed the need
to include upstream determinants of diabetes and other
NCDs in any policymaking endeavour. These include
the broader determinants of diet and physical activity,
such as the price and availability of different foods and
the structure of the built environment. The CDC model
explicitly excluded these determinants as outside the
model boundaries set by stakeholders partly due to a
lack of sufficient evidence to satisfy stakeholders and
partly because the model, as it was constructed, satisfied
the purposes of that study [16]. The policies of interest
for evaluation in this study also differ from those of the
CDC and thus the model must follow the needs of the
context for which it is being designed. Despite these
differences, a core epidemiological structure exists in the
CDC model, which is generic and will be used as the
starting point for model adaptation and development
(Fig. 2).
This initial concept model will be used to engage
stakeholders and promote systems thinking during
in-depth interviews. The model focuses explicitly on
incorporating shared risk factors for NCDs and their
upstream determinants, which are potential targets of
policy interventions. Total diabetes prevalence will be
used as the primary outcome measure of interest (in
system dynamics referred to as the ‘reference mode’) for
policy interventions.
The interviews will be used to gather qualitative data
from stakeholders on their perspectives regarding diabetes,
its determinants, and effects in their own countries and the
region. The development will be an iterative process with
each phase informing the other, thus refining the model. As
part of this iterative process, the model structure will be
compared to the CDC diabetes model [23]. This will
Fig. 1 Overview of process* for system dynamics model development. *Developing a system dynamics model is not a strictly linear process
though it has a progression; it is marked by iteration, revision and feedback at each point in the process
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provide an additional way of promoting critical consider-
ation of the model structure through understanding the
basis and the consequences of any differences.
Review of existing qualitative data and stakeholder
selection
The POSD evaluation study conducted in-depth inter-
views with NCD experts in countries on their views
regarding progress on policies laid out by the POSD.
Using data collected from the evaluation the investigators
will undertake a formal thematic qualitative analysis of
existing interview data as it relates to drivers and determi-
nants of the diabetes system in the region, particularly to
the upstream determinants of diet and physical activity
through obesity. The review will also be used to identify
stakeholders to be invited to participate in and for follow-
up in-depth interviews, and insights from the prior inter-
views will be revisited and discussed in these planned
follow-ups. Further stakeholders will be identified using
snowball sampling and referral from contacts within and
using the existing POSD network in the three project
countries. For practical reasons, and in keeping with
recommendations for model building [24], no more than
10 stakeholders will be selected for each country.
Review of quantitative evidence
A systematic literature review will provide evidence on the
quantitative historical relationships between variables in
the model. The empirical data will be used to calibrate the
model. A systematic review is being conducted of studies
performed within the last 10 years in the Caribbean
describing the prevalence of type 2 diabetes, its risk factors
Fig. 2 Overview of core conceptual model to be further developed with stakeholders and policymakers
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and their social determinants, and healthcare coverage
and outcomes in people with diabetes. This evidence
review will build upon recent scoping and systematic
reviews into the social determinants of diabetes in the
Caribbean [25]. In addition, any available, unpublished,
datasets in the three project countries will be identified.
This will be facilitated by the POSD evaluation and
ongoing work collating mortality and risk factor datasets
within the CARICOM countries. In addition, stakeholders
will be asked during the qualitative interviews, if they
know of any local datasets.
In the absence of sufficient quantitative data from the
Caribbean for a relationship within the conceptual model,
it will be necessary to use data for calibration from other
parts of the world. Care will be taken to use data matching
a context and ethnic mix as close as possible to the
Caribbean populations and such data will be assumed to
come with greater uncertainty in the calibration exercise.
Stakeholder interviews and new data collection
Stakeholders for the in-depth qualitative interviews will
involve members of the Ministries of Health, including
the Chief Medical Officer or NCD focal point, other rele-
vant government ministries, such as education, transport
and agriculture; leaders from civil society organisations,
including diabetes organisations and church groups; and
prominent private sector leaders.
A semi-structured interview guide will be used, eliciting
stakeholders’ estimation and gaining feedback on the draft
preliminary model, and contextual information of trends in
diabetes, obesity and physical inactivity, and the underlying
determinants in their settings; similarly, stakeholder views
on trends in access to diabetes care and determinants of
blood glucose, pressure, and lipid control and their
determinants will be explored. All interviews will be
recorded, transcribed verbatim and analyzed thematically
[26], and used to generate causal maps [27].
Country-level model building
A conceptual model will be developed for each of the
three study countries using stakeholder input and data
gathered from the evidence review. Stakeholders will be
given a report of the conceptual model and given an
opportunity to submit changes for one round of iteration.
The models will be finalised and a quantitative model
produced for each country using country-level data where
possible. The models will be compared and simulations
will be produced using a single set of policies and scenarios
for testing.
Group model building and an inter-country regional
model
The investigators will use a revised conceptual model to
include input from country-level work as the basis for the
development of an inter-country regional model. The
model development will include stakeholders with regional
expertise who will meet for a group model building
workshop. Over 2 days, the workshop will provide an
introduction to system dynamics modelling and systems
thinking to stakeholders to develop a regional diabetes
model. Following the model building workshop, stake-
holders will be given two opportunities for revision and
feedback. These comments will be included in the revision
and development of the model. Once there is general agree-
ment from stakeholders on the conceptual model, evidence
from quantitative data collection will be applied to develop
a quantitative model.
Quantitative inter-country regional model, validation and
policy simulations
Once the conceptual model has been finalised, estimates
for each of the parameters and variables will be
incorporated using data obtained from the quantitative data
collection. The model will be used to try and replicate
trends in risk factors and outcomes available from studies
in the region as much as possible from 2000 to the present.
One of the time frames that will be used for simulations is
to 2025 in order to help guide potential policies for
achieving relevant targets of the WHO Global Monitoring
Framework [22]. The model will also be extended to 2050
to give enough time to assess the presence and influence of
slow feedback mechanisms. Testing the model will involve
undertaking sensitivity analyses for the parameters included
and also ‘extreme case’ modelling [28] will help to assess
the plausibility of the simulations being produced.
The primary targets for the option appraisal and simula-
tion will be centred on policy recommendations generated
from the POSD evaluation study, relevant targets in the
Global Monitoring Framework, and policies identified by
stakeholders, including no increase in obesity or diabetes
prevalence by 2025, and a reduction in premature diabetes
mortality by 25%. Various alternative scenarios, including
adoption and implementation of policies related to risk
factors and treatment, exogenous scenarios and testing one
against the other, will be evaluated using the simulations.
Potential policies will be evaluated alone and in plausible
combinations, as guided by stakeholders, against a timeline
of achievement by 2025, without a time horizon, and
estimating a time horizon for achievement.
Special attention will be put into stratifying the model
by gender and socioeconomic status to explore how the
potential interventions for the prevention and control of
diabetes impact on health equity.
Stakeholder model evaluation
Once the quantitative model has been tested, a simulation
test environment (management flight simulator) will be
developed for stakeholders to interact with the model.
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Stakeholders will be interviewed and surveyed to gather
feedback on the model building process, utilisation of the
simulation tool, and how process and outputs could be
made more useful to them.
Ethical review
The study has been submitted for ethical review and
approved by the University of the West Indies, Cave Hill/
Barbados Ministry of Health Research Ethics Committee/
Institutional Review board.
Discussion
The model is being constructed as part of a development
project with a view toward expanding in the future. One
area of particular interest is the incorporation of economic
and cost estimates to the simulations to better serve
policymakers in understanding ‘best buys’ and the cost-
benefit relationships related to the policy choices being
modelled. As part of this effort, the project is looking to
establish external collaborations with economists in the
region and those with expertise in systems thinking.
Diabetes shares risk factors and outcomes with the other
three major classes of NCDs (cardiovascular disease,
chronic lung diseases and cancers). Together, these four
disease categories make up 82% of all deaths due to chronic
disease and the burden is especially high in LMICs [5]. It is
of high public health importance to consider the burden
and effects of all NCDs in the CARICOM region. As a
result, any further development of the model must take into
account how interventions affect the shared risk factors
and outcomes of all of these diseases. In addition, in keep-
ing with system dynamics methodology, the model will be
considered as in development with further iteration, adap-
tation and modification encouraged for its improvement.
The model is designed to promote the engagement of
policymakers in evidence-based decision-making and policy
design. Collaboration between researchers and policy-
makers and skills-building are major determinants influen-
cing the use of evidence for supporting policy [29]. The
protocol described here makes explicit these interactions
through group model building and integrates learning in
systems modelling and interpretation for policymakers. Fur-
thermore, the continued development of the model with
stakeholders will provide a platform for sustained inter-
action and engagement in policy development and support.
The methodology used for the development of the model
may also be of interest to other developing countries facing
a similar diabetes burden under constrained resources. The
methodology will be written up as a manual for use by
other interested regions and in particular Small Island
Developing States, including in the Western Pacific and
Indian Ocean, faced with similar disease burdens, policy
issues and resource constraints as the Caribbean region.
Abbreviations
CARICOM: Caribbean Community; CDC: Centers for Disease Control;
LMICs: low- and middle-income countries; NCDs: non-communicable
diseases; POSD: Port of Spain Declaration; USA: United States of America
Acknowledgements
The authors would like to thank contributions from colleagues at the
University of the West Indies Chronic Disease Research Centre.
Funding
The project is funded by a health initiatives development grant sponsored
by the DFID/MRC/Wellcome Trust/ESRC. Reference: MR/N005384/1.
Availability of data and material
Upon completion, the model and its supporting data will be made available
through a publicly accessible website. Please contact the corresponding
author for details.
Authors’ contributions
NU (principal investigator) had the original idea for the study and led the
design of the study and the writing of the original protocol, the applications
for grant funding and ethical approval, and this manuscript. CG, LG, JW and
ER (co-investigators) contributed to the design and the writing of the
original protocol and grant application. CG devised the qualitative data
collection, sampling and analysis element of the study. JW and ER
contributed to the development of the design for model development and
group model building. IH (co-investigator) contributed to the development
of the quantitative data collection and analysis. TAS (co-investigator)
contributed to the policy analysis and stakeholder identification and
engagement strategy. LG (study coordinator and research lead) contributed
to the design, protocol and applications for ethical approval for parts of the
study. All authors contributed to the critical revision of the paper and
approved the final version.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
The study has received ethical approval from the University of the West
Indies Cave Hill/Barbados Ministry of Health Research Ethics Committee/
Institutional Review Board. Written informed consent will be sought from
study participants.
Author details
1University of the West Indies, Cave Hill, Barbados. 2MRC Epidemiology Unit,
University of Cambridge, Cambridge, United Kingdom. 3Nijmegen School of
Management, Radboud University, Nijmegen, The Netherlands.
Received: 31 August 2016 Accepted: 26 September 2016
References
1. Guariguata L, Whiting DR, Beagley J, Linnenkamp U, Hambleton I, Cho NH,
et al. Global estimates of diabetes prevalence in adults for 2013 and
projections for 2035 for the IDF Diabetes Atlas. Diabetes Res Clin Pract.
2014;103(2):137–49.
2. Roglic G, Unwin N. Mortality attributable to diabetes: estimates for the year
2010. Diabetes Res Clin Pract. 2010;87(1):15–9.
3. Zhang P, Zhang X, Brown J, Vistisen D, Sicree R, Shaw J, et al. Global
healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin
Pract. 2010;87(3):293–301.
4. Yisahak SF, Beagley J, Hambleton IR, Narayan KMV. Diabetes in north America
and the Caribbean: an update. Diabetes Res Clin Pract. 2014;103(2):223–30.
5. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global
and regional mortality from 235 causes of death for 20 age groups in 1990
and 2010: a systematic analysis for the Global Burden of Disease Study
2010. Lancet. 2012;380(9859):2095–128.
Guariguata et al. Health Research Policy and Systems  (2016) 14:79 Page 6 of 7
6. Hennis AJM, Fraser HS, Jonnalagadda R, Fuller J, Chaturvedi N. Explanations for
the High Risk of Diabetes-Related Amputation in a Caribbean Population of Black
African Descent and Potential for Prevention. Diabetes Care. 2004;27(11):2636–41.
7. Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, et al.
Global, regional, and national prevalence of overweight and obesity in
children and adults during 1980–2013: a systematic analysis for the Global
Burden of Disease Study 2013. Lancet. 2014;384(9945):766–81.
8. Hallal PC, Andersen LB, Bull FC, Guthold R, Haskell W, Ekelund U. Global
physical activity levels: surveillance progress, pitfalls, and prospects. Lancet.
2012;380(9838):247–57.
9. Declaration of Port-of-Spain : Uniting to stop the Epidemic of Chronic NCDs.
2007. http://caricom.org/media-center/communications/statements-from-
caricom-meetings/declaration-of-port-of-spain-uniting-tostop-the-epidemic-
of-chronic-ncds. Accessed 11 Mar 2016.
10. World Health Organization. Global action plan for the prevention and control
of noncommunicable diseases 2013–2020. Geneva: WHO; 2013. http://www.
who.int/nmh/events/ncd_action_plan/en/. Accessed 11 Mar 2016.
11. Samuels TA, Kirton J, Guebert J. Monitoring compliance with high-level
commitments in health: the case of the CARICOM Summit on Chronic Non-
Communicable Diseases. Bull World Health Organ. 2014;92(4):270–6B.
12. Stuckler D, Siegel K. Sick Societies: Responding to the global challenge of
chronic disease. 1st ed. Oxford: University Press; 2011.
13. Kumanyika SK, Parker L, Sim LJ. Committee on an Evidence Framework for
Obesity Prevention Decision Making; Food and Nutrition Board; Institute of
Medicine. Bridging the Evidence Gap in Obesity Prevention: A Framework to
Inform Decision Making. Washington, DC: National Academies Press; 2010.
14. Vennix JAM. Group Model Building: Facilitating Team Learning Using
System Dynamics. New Jersey: Wiley; 1996.
15. Homer JB, Hirsch GB. System dynamics modeling for public health:
background and opportunities. Am J Public Health. 2006;96(3):452–8.
16. Jones AP, Homer JB, Murphy DL, Essien JDK, Milstein B, Seville DA.
Understanding diabetes population dynamics through simulation modeling
and experimentation. Am J Public Health. 2006;96(3):488–94.
17. Homer J, Milstein B, Dietz W, Buchner D, Majestic E. Obesity population dynamics:
exploring historical growth and plausible futures in the US. http://www2.cdc.gov/
syndemics/pdfs/Obesity%20population%20dynamics%20(Homer,%20ISDC-06).
pdf. Accessed 11 Mar 2016.
18. Homer J, Milstein B, Wile K, Trogdon J, Huang P, Labarthe D, et al.
Simulating and evaluating local interventions to improve cardiovascular
health. Prev Chronic Dis. 2010;7(1):A18.
19. Hirsch G, Homer J, Evans E, Zielinski A. A System Dynamics Model for Planning
Cardiovascular Disease Interventions. Am J Public Health. 2010;100(4):616–22.
20. Kenealy T, Rees D, Sheridan N, Moffitt A, Tibby S, Homer J. A “whole of
system” approach to compare options for CVD interventions in Counties
Manukau. Aust N Z J Public Health. 2012;36(3):263–8.
21. Mahamoud A, Roche B, Homer J. Modelling the social determinants of
health and simulating short-term and long-term intervention impacts for
the city of Toronto, Canada. Soc Sci Med. 2013;93:247–55.
22. World Health Organization. Draft comprehensive global monitoring framework
and targets for the prevention and control of noncommunicable diseases.
Geneva: WHO; 2013. (Sixty-sixth World Health Assembly). Report No.: A66/8.
23. Milstein B, Jones A, Homer JB, Murphy D, Essien J, Seville D. Charting
plausible futures for diabetes prevalence in the United States: a role for
system dynamics simulation modeling. Prev Chronic Dis. 2007;4(3):A52.
24. Hovmand P. Community Based System Dynamics. Berlin: Springer Science
& Business Media; 2013.
25. Sobers-Grannum N, Murphy MM, Nielsen A, Guell C, Samuels TA, Bishop L,
et al. Female gender is a social determinant of diabetes in the Caribbean: a
systematic review and meta-analysis. PLoS One. 2015;10(5):e0126799.
26. Green J, Thorogood N. Qualitative Methods for Health Research. Thousand
Oaks: SAGE Publications; 2004.
27. Kim H, Andersen DF. Building confidence in causal maps generated from
purposive text data: mapping transcripts of the Federal Reserve. Syst Dyn
Rev. 2012;28(4):311–28.
28. Barlas Y. Model validation in system dynamics. In: Proceedings of the 1994
International System Dynamics Conference. Scotland: Sterling; 1994. p. 1–10.
http://www.systemdynamics.org/conferences/1994/proceed/papers_vol_1/
barla002.pdf. Accessed 11 Mar 2016.
29. Oliver K, Innvar S, Lorenc T, Woodman J, Thomas J. A systematic review of
barriers to and facilitators of the use of evidence by policymakers. BMC
Health Serv Res. 2014;14:2.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Guariguata et al. Health Research Policy and Systems  (2016) 14:79 Page 7 of 7
